Article Listing - Akzo marries Diosynth and Organon

CANADA PRIVATIZES DRUG APPROVALS

9 March 1992

In an attempt to speed up the drug marketing approval system, Canada's federal Department of Health and Welfare is now...

WORLD NEWS IN BRIEF

9 March 1992

- In Vietnam, the Ministry of Health is to set up a new Health Inspectorate to oversee implementation of the...

CAL BIO FOURTH QUARTER LOSS

9 March 1992

California Biotechnology of the USA reported a net loss of $17.2 million for the 1991 fiscal year. The loss was...

SYNTEX POSTS STRONG 2ND QTR

9 March 1992

Syntex Corp performed well in the second quarter of fiscal 1992 ended January 31, with net sales of $530.9 million,...

FUJISAWA KOREA JV COMPLETED

9 March 1992

Japan's Fujisawa Pharmaceuticals has revealed that its joint venture plant in South Korea with that country's largest drugmaker, Dong-A Pharmaceuti-cal,...

TEVA PHARMA NET INCOME UP 25%

9 March 1992

Israel's leading drugmaker Teva Pharmaceuticals reported net income of NIS53.2 million ($23.3 million) for the whole of 1991. Sales for...

TRIAL GO-AHEAD FOR DEPRENYL'S ALZENE

9 March 1992

Toronto, Canada-based Deprenyl Research Limited has received approval to test the putative anti-Alzheimer's disease drug alzene in humans at medical...

IL-2 APPROVED IN UK

9 March 1992

Eurocetus has been granted approval in the UK to market its version of IL-2, Proleukin, for the treatment of patients...

CAL BIO NAME CHANGE

9 March 1992

The US biotechnology company California Biotechnology has changed its name to Scios Inc. "In anticipation of bringing our pharmaceutical products...

ARES-SERONO 1991 RESULTS

9 March 1992

Swiss pharmaceutical company Ares-Serono made sales of $751.1 million in fiscal 1991, rising 15% on the previous year. Net profit...

Showing 94691-94700 of 95360 articles

Go to beginningPreviousNextGo to end